004310 — Hyundai Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Hyundai Pharmaceutical Co, fiscal year end - November 30th, KRW millions except per share, conversion factor applied.

	2021 November 30th	2022 November 30th	2023 November 30th	2024 November 30th	2025 November 30th
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	21,916	33,779	18,291	10,277	2,504
Net Total Accounts Receivable
Net Total Receivables	40,336	42,461	38,973	38,652	44,656
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	84,896	101,643	85,473	79,562	80,828
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	29,261	28,601	29,436	37,446	39,245
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	163,857	181,159	154,629	156,396	163,216
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	45,850	80,696	65,334	58,687	71,411
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	77,257	94,604	69,968	77,322	81,112
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	86,600	86,555	84,661	79,074	82,103
Total Liabilities & Shareholders' Equity	163,857	181,159	154,629	156,396	163,216
Total Common Shares Outstanding